Study Evaluating the Efficacy of DVS-233 in Fibromyalgia
NCT ID: NCT00301431
Last Updated: 2007-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2/PHASE3
1050 participants
INTERVENTIONAL
2006-08-31
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DVS-233
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Treatment with other drugs for fibromyalgia with 14 days of study start or during the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Wyeth is now a wholly owned subsidiary of Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huntsville, Alabama, United States
Mobile, Alabama, United States
Phoenix, Arizona, United States
Anaheim, California, United States
Sacramento, California, United States
San Diego, California, United States
Santa Ana, California, United States
Walnut Creek, California, United States
Denver, Colorado, United States
Cromwell, Connecticut, United States
Brooksville, Florida, United States
DeLand, Florida, United States
Delray Beach, Florida, United States
Jacksonville, Florida, United States
Miami, Florida, United States
Palm Beach Gardens, Florida, United States
Pembroke Pines, Florida, United States
St. Petersburg, Florida, United States
Sunrise, Florida, United States
Tamarac, Florida, United States
Tampa, Florida, United States
Atlanta, Georgia, United States
Decatur, Georgia, United States
Smyrna, Georgia, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Indianapolis, Indiana, United States
Lexington, Kentucky, United States
Lexington, Kentucky, United States
Rockville, Maryland, United States
Boston, Massachusetts, United States
Newton, Massachusetts, United States
Lansing, Michigan, United States
Kansas City, Missouri, United States
St Louis, Missouri, United States
Las Vegas, Nevada, United States
Clementon, New Jersey, United States
Raleigh, North Carolina, United States
Cincinnati, Ohio, United States
Dayton, Ohio, United States
Oklahoma City, Oklahoma, United States
Oklahoma City, Oklahoma, United States
Tulsa, Oklahoma, United States
Duncansville, Pennsylvania, United States
Harleysville, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Sellersville, Pennsylvania, United States
West Reading, Pennsylvania, United States
Warwick, Rhode Island, United States
Charleston, South Carolina, United States
Summerville, South Carolina, United States
Bristol, Tennessee, United States
Chattanooga, Tennessee, United States
Memphis, Tennessee, United States
Austin, Texas, United States
Dallas, Texas, United States
San Antonio, Texas, United States
Middleton, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3151A4-327
Identifier Type: -
Identifier Source: org_study_id